2 UK small-cap stocks I’d buy this December

UK small-cap stocks can offer exciting investment opportunities. These two small-cap AIM-listed stocks are on my watchlist for December.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

UK small-cap stocks can offer exciting investments that can deliver outstanding long-term returns. The FTSE AIM is a good place to look for smaller companies to invest in. However, the prices of small-cap stocks tend to be more volatile than FTSE 100 or even FTSE 250 stocks.

At the moment, with the Covid-19 pandemic still ongoing, and Brexit just around the corner, risks for small-cap stocks, in particular, are high. However, I am willing to accept the risks and have a long enough time horizon to ride out any rough patches. With that in mind, here are two UK small-cap stocks that I would consider buying for December 2020 and beyond.

A small-cap healthcare stock

Hospitals have performed fewer surgeries and procedures this year. For a surgical and advanced wound care small-cap stock like Advanced Medical Solutions (LSE: AMS), this is bad news. Half-year 2020 revenue and profit before tax both declined, by 19% and 62% year-on-year respectively. But things are already getting better in most of the markets the company serves. The recent vaccine developments are encouraging and could potentially end the pandemic sometime next year. Hospitals returning to normal working conditions is a boon for AMS’s sales and bottom line.

Recent developments include two product approvals in India, patents granted in the UK and US for an advanced dressing, and a CE mark being awarded for another. Just yesterday, AMS completed the £22m cash acquisition of a wound care and bio-diagnostics coating business, that was also a key supplier. 

These developments position AMS well for making the most of a recovery in surgical caseloads. Also, shopping for acquisitions and increasing R&D investment to £3.8m this year speaks volumes about AMS’s financial health and management confidence in the medium- and long-term prospects for this UK small-cap stock.

An AIM technology stock

Quartix Holdings (LSE: QTX) is one of Europe’s leading suppliers of subscription-based vehicle tracking systems, software, and services. In January 2020 the company picked up 555 new customers. Then, the Covid-19 pandemic knocked customer acquisition levels down to 200. However, 474 customers were added in September this year, meaning the impact was not as dramatic nor as long-lasting as once feared. All in all, across all markets served, the number of vehicles using Quartix’s products and services have increased so far this year. However, Quartix’s insurance telematics business, which relies heavily on newly insured drivers, slumped, but it does represent only 16% of total revenue.

I think UK small-cap stock Quartix has a lot going for it. Quartix’s customers have had the company’s tracking equipment installed on their vehicles and have learnt how to use its software. Switching to another product is expensive and time-consuming. This suggests customers will stick around. Those customers pay subscriptions for continuing use after installation. Recurring, predictable revenue is great for a growing company.

And Quartix does look good for continued growth. Its customers tend to be owners of fleets of cars and vans. Quartix gives them the ability to locate their vehicles 24/7, make scheduling of deliveries easier, check millage, and report driver locations to their customers. Quartix provides an essential service for customers looking to improve their fleet management. The increase in online delivery is just one trend that is increasing the need for fleet management.

James J. McCombie has no position in any of the shares mentioned. The Motley Fool UK has recommended Advanced Medical Solutions and Quartix. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Snowing on Jubilee Gardens in London at dusk
Investing Articles

£5,000 put into Nvidia stock last Christmas is already worth this much!

A year ago, Nvidia stock was already riding high -- but it's gained value since. Our writer explores why and…

Read more »

Investing Articles

Are Tesco shares easy money heading into 2026?

The supermarket industry is known for low margins and intense competition. But analysts are bullish on Tesco shares – and…

Read more »

Smiling black woman showing e-ticket on smartphone to white male attendant at airport
Investing Articles

Can this airline stock beat the FTSE 100 again in 2026?

After outperforming the FTSE 100 in 2025, International Consolidated Airlines Group has a promising plan to make its business more…

Read more »

Investing Articles

1 Stocks and Shares ISA mistake that will make me a better investor in 2026

All investors make mistakes. The best ones learn from them. That’s Stephen Wright’s plan to maximise returns from his Stocks…

Read more »

Portrait Of Senior Couple Climbing Hill On Hike Through Countryside In Lake District UK Together
Investing Articles

I asked ChatGPT if £20,000 would work harder in an ISA or SIPP in 2026 and it said…

Investors have two tax-efficient ways to build wealth, either in a Stocks and Shares ISA or SIPP. Harvey Jones asked…

Read more »

Investing Articles

How much would I need invested in an ISA to earn £2,417 a month in passive income?

This writer runs the numbers to see what it takes in an ISA to reach £2,417 a month in passive…

Read more »

Investing Articles

Rolls-Royce shares or Melrose Industries: Which one is better value for 2026?

Rolls-Royce shares surged in 2025, surpassing most expectations. Dr James Fox considers whether it offers better value than peer Melrose.

Read more »

Investing Articles

3 top Vanguard ETFs to consider for an ISA or SIPP in 2026

Edward Sheldon believes that these three Vanguard ETFs could be solid investments for a pension (SIPP) or investment account in…

Read more »